• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年女性宫颈癌发病率——生物学因素还是筛查史?

Cervical cancer incidence in elderly women-biology or screening history?

作者信息

Lynge Elsebeth, Lönnberg Stefan, Törnberg Sven

机构信息

Department of Public Health, University of Copenhagen, Denmark.

Cancer Registry of Norway, Oslo, Norway.

出版信息

Eur J Cancer. 2017 Mar;74:82-88. doi: 10.1016/j.ejca.2016.12.021. Epub 2017 Feb 11.

DOI:10.1016/j.ejca.2016.12.021
PMID:28335890
Abstract

AIM

In many countries, the age-specific pattern of cervical cancer incidence is currently bipolar with peaks at for instance 45 and 65 years of age. Consequently, a large proportion of cervical cancer cases are presently diagnosed in women above the screening age. The purpose of the study was to determine whether this bipolar pattern in age-specific incidence of cervical cancer reflects underlying biology or can be explained by the fact that the data come from birth cohorts with different screening histories.

METHODS

Combination of historical data on cervical screening and population-based cancer incidence data from Denmark 1943-2013, Finland and Norway 1953-2013, and Sweden 1958-2013.

RESULTS

Since the implementation of screening, the incidence of cervical cancer has decreased for each successive birth cohort. All birth cohorts showed a unipolar age-specific pattern. In unscreened women in Denmark and Sweden, the incidence peaked around the age of 50; the peak was less marked in Finland; while peak age for unscreened women could not be determined for Norway due to widespread opportunistic screening. The current old-age peak in the incidence of cervical cancer represents residuals from unscreened or underscreened birth cohorts.

CONCLUSION

The current bipolar pattern in age-specific incidence of cervical cancer can largely be explained by the different screening histories of successive birth cohorts. While it is reasonable to offer screening to elderly women today, birth cohort trends in disease burden should be carefully monitored to justify permanent changes in upper screening age.

摘要

目的

在许多国家,宫颈癌发病率的年龄特异性模式目前呈双相性,例如在45岁和65岁出现峰值。因此,目前很大一部分宫颈癌病例是在筛查年龄以上的女性中诊断出来的。本研究的目的是确定宫颈癌年龄特异性发病率的这种双相模式是反映了潜在生物学特性,还是可以用数据来自具有不同筛查历史的出生队列这一事实来解释。

方法

结合丹麦1943 - 2013年、芬兰和挪威1953 - 2013年以及瑞典1958 - 2013年的宫颈筛查历史数据和基于人群的癌症发病率数据。

结果

自实施筛查以来,每个连续出生队列的宫颈癌发病率都有所下降。所有出生队列均呈现单极年龄特异性模式。在丹麦和瑞典未接受筛查的女性中,发病率在50岁左右达到峰值;在芬兰峰值不太明显;而由于广泛的机会性筛查,挪威未接受筛查女性的峰值年龄无法确定。目前宫颈癌发病率的老年峰值代表了未筛查或筛查不足的出生队列的残留情况。

结论

目前宫颈癌年龄特异性发病率的双相模式在很大程度上可以用连续出生队列不同的筛查历史来解释。虽然如今为老年女性提供筛查是合理的,但应仔细监测出生队列的疾病负担趋势,以证明筛查年龄上限的永久性变化是合理的。

相似文献

1
Cervical cancer incidence in elderly women-biology or screening history?老年女性宫颈癌发病率——生物学因素还是筛查史?
Eur J Cancer. 2017 Mar;74:82-88. doi: 10.1016/j.ejca.2016.12.021. Epub 2017 Feb 11.
2
Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.1980 - 2012年丹麦老年女性妇科癌症的发病趋势
Acta Oncol. 2016;55 Suppl 1:65-73. doi: 10.3109/0284186X.2015.1115119. Epub 2016 Jan 19.
3
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.全球宫颈癌发病率趋势:筛查对疾病危险因素变化的影响。
Eur J Cancer. 2013 Oct;49(15):3262-73. doi: 10.1016/j.ejca.2013.04.024. Epub 2013 Jun 8.
4
Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population.芬兰和爱沙尼亚宫颈癌的发病率和死亡率趋势:筛查人群与未筛查人群对比
Eur J Cancer. 1993;29A(5):745-9. doi: 10.1016/s0959-8049(05)80359-4.
5
The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.冰岛及北欧的子宫颈癌筛查项目:截至1995年的发病率及死亡率趋势
Acta Obstet Gynecol Scand. 1999 Jul;78(6):478-85.
6
Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.丹麦、芬兰、挪威和瑞典的宫颈癌、阴道癌和外阴癌发病和生存趋势及其对治疗的影响。
BMC Cancer. 2022 Apr 26;22(1):456. doi: 10.1186/s12885-022-09582-5.
7
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.北欧国家癌症发病率趋势。北欧五个癌症登记处的合作研究。
Acta Pathol Microbiol Immunol Scand Suppl. 1986;288:1-151.
8
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.13个欧洲国家宫颈鳞状细胞癌发病率趋势:风险变化及筛查的影响
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):677-86. doi: 10.1158/1055-9965.EPI-04-0569.
9
The temporal and age-dependent patterns of hysterectomy-corrected cervical cancer incidence rates in Denmark: a population-based cohort study.丹麦子宫切除术后校正宫颈癌发病率的时间和年龄依赖性模式:一项基于人群的队列研究。
Acta Obstet Gynecol Scand. 2017 Feb;96(2):150-157. doi: 10.1111/aogs.13057. Epub 2016 Dec 28.
10
The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.大规模筛查对子宫颈鳞状细胞癌和腺癌发病率及死亡率的影响。
Obstet Gynecol. 1995 Jun;85(6):1017-21. doi: 10.1016/0029-7844(95)00063-W.

引用本文的文献

1
Human Papillomavirus and Other Relevant Issues in Cervical Cancer Pathogenesis.人乳头瘤病毒与宫颈癌发病机制中的其他相关问题。
Int J Mol Sci. 2025 Jun 10;26(12):5549. doi: 10.3390/ijms26125549.
2
The Risk of Developing Cervical Cancer in the Elderly: Who Benefits From Screening After the Age of 60?老年人患宫颈癌的风险:60岁以后哪些人能从筛查中获益?
J Low Genit Tract Dis. 2025 Jul 1;29(3):229-234. doi: 10.1097/LGT.0000000000000893. Epub 2025 Apr 18.
3
Worldwide burden of cervical human papillomavirus (HPV) in women over 50 years with abnormal cytology: a systematic review and meta-analysis.
50岁以上细胞学异常女性的全球宫颈人乳头瘤病毒(HPV)负担:一项系统评价和荟萃分析
BMJ Glob Health. 2025 Apr 2;10(4):e017309. doi: 10.1136/bmjgh-2024-017309.
4
Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden.老年女性中基于人乳头瘤病毒(HPV)的子宫颈癌初筛评估:瑞典一项随机医疗政策试验的长期随访
PLoS Med. 2024 Dec 19;21(12):e1004505. doi: 10.1371/journal.pmed.1004505. eCollection 2024 Dec.
5
Anogenital HPV-Related Cancers in Women: Investigating Trends and Sociodemographic Risk Factors.女性肛门生殖器人乳头瘤病毒相关癌症:探究趋势及社会人口学风险因素
Cancers (Basel). 2024 Jun 8;16(12):2177. doi: 10.3390/cancers16122177.
6
Effect of Test History at Ages 50-64 on Later Cervical Cancer Risk: A Population-based Case-control Study.50-64 岁时的检测史对后期宫颈癌风险的影响:基于人群的病例对照研究。
Cancer Res Commun. 2023 Sep 11;3(9):1823-1829. doi: 10.1158/2767-9764.CRC-23-0191. eCollection 2023 Sep.
7
A cervical screening initiative for elderly women in Denmark.丹麦为老年女性开展的宫颈癌筛查计划。
Acta Obstet Gynecol Scand. 2023 Jun;102(6):791-800. doi: 10.1111/aogs.14574. Epub 2023 Apr 27.
8
Cervical cancer mortality in Norway according to screening attendance and age.挪威宫颈癌死亡率与筛查参与率及年龄的关系。
Acta Obstet Gynecol Scand. 2022 Sep;101(9):952-959. doi: 10.1111/aogs.14402. Epub 2022 Jun 11.
9
LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future.长链非编码 RNA ABHD11-AS1 通过靶向 miR-1254 参与宫颈癌的进展,是未来宫颈癌诊断和治疗的关键。
J Healthc Eng. 2022 Feb 10;2022:8387458. doi: 10.1155/2022/8387458. eCollection 2022.
10
Associations of treated and untreated human papillomavirus infection with preterm delivery and neonatal mortality: A Swedish population-based study.治疗和未治疗的人乳头瘤病毒感染与早产和新生儿死亡的关系:一项瑞典基于人群的研究。
PLoS Med. 2021 May 10;18(5):e1003641. doi: 10.1371/journal.pmed.1003641. eCollection 2021 May.